Article Details
Retrieved on: 2019-03-20 18:27:31
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Vanguard Group</b> Inc. boosted its position in shares of Cellular Biomedicine Group Inc (NASDAQ:CBMG) by 4.2% during the 3rd quarter, according to ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here